Wave Life Sciences Ltd. (WVE) — 10-Q Filings
All 10-Q filings from Wave Life Sciences Ltd.. Browse 7 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (7)
- 10-Q Filing — Apr 28, 2026
-
Wave Life Sciences Narrows Quarterly Loss, Boosts R&D Spending
— Nov 10, 2025 Risk: high
Wave Life Sciences Ltd. reported a net loss of $53.852 million for the three months ended September 30, 2025, an improvement from the $61.780 million net loss i -
Wave Life Sciences Narrows Q2 Loss to $48.5M on R&D Cuts
— Jul 30, 2025 Risk: high
Wave Life Sciences Ltd. reported a net loss of $48.5 million for the quarter ended June 30, 2025, a decrease from the $57.2 million net loss in the prior-year q -
Wave Life Sciences Files Q1 2025 10-Q
— May 8, 2025 Risk: medium
Wave Life Sciences Ltd. filed its 10-Q for the period ending March 31, 2025. The company's business address is in Singapore, with a mailing address in Cambridge -
Wave Life Sciences Q3 2024 Update
— Nov 12, 2024 Risk: medium
Wave Life Sciences Ltd. reported its third-quarter financial results for the period ending September 30, 2024. The company's filing details its financial positi -
Wave Life Sciences Files Q2 2024 10-Q
— Aug 8, 2024 Risk: medium
Wave Life Sciences Ltd. filed its 10-Q for the period ending June 30, 2024. The company reported on its financial condition and business operations, including d -
Wave Life Sciences Ltd. Files 10-Q for Period Ending March 31, 2024
— May 10, 2024 Risk:
Wave Life Sciences Ltd. (WVE) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Wave Life Sciences Ltd. filed a 10-Q report for the period ending Ma
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX